Feedback / Questions
trabedersen (OT-101) - Autotelic, Mateon Therapeutics
https://www.globenewswire.com/news-release/2020/12/30/2151812/0/en/MATEON-S-GLOBAL-STUDY-FOR-OT-101-TGF-%CE%B2-INHIBITOR-AGAINST-COVID-19-ENROLLS-AND-TREATS-ITS-FIRST-PATIENT.html
Dec 30, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next